Trade Zimmer Biomet Holdings - ZBH CFD

Trading Conditions

• Spread: 0.64
• Long position overnight feeLong position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position-0.026179 %(-$1.05)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position0.003957 %($0.16)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-$1.05)

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  ($0.16)

Key Stats

• Prev. Close: 119.49
• Open: 122.56
• 1-Year Change: -11.35%
• Day's Range: 117.69 - 122.56

Zimmer Company profile

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas and Global Businesses, consisting principally of the United States and other North, Central and South American markets; Europe, Middle East and Africa (EMEA), consisting principally of France, Germany, Italy, Spain and the United Kingdom, and Asia Pacific, consisting primarily of Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong and Malaysia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Zimmer Biomet Holdings Inc revenues increased 12% to $7.84B. Net income before extraordinary items totaled $431.7M vs. loss of $143.9M. Revenues reflect Americas Orthopedics segment increase of 11% to $4.1B, EMEA segment increase of 19% to $1.53B, Americas Spine and Global Dental segment increase of 13% to $882M, Americas segment increase of 11% to $4.8B, EMEA segment increase of 20% to $1.67B.

Equity composition

Common Stock $.01 Par, 03/11, 1B auth., 255,200,000 issd. less 63,200,000 shs. in Treas. @ $3.78B.Insider owns 0.13%.